Financial Performance - The company's operating revenue for Q1 2023 was approximately ¥146.72 million, representing a decrease of 37.67% compared to the same period last year[4] - The net profit attributable to shareholders of the listed company was a loss of approximately ¥12.20 million, with a net profit excluding non-recurring gains and losses of approximately ¥12.75 million[4] - The net loss for Q1 2023 was CNY 12.12 million, compared to a net loss of CNY 10.67 million in Q1 2022[22] - Operating profit for Q1 2023 was a loss of CNY 12.12 million, compared to a loss of CNY 9.76 million in the same period last year[22] - The total comprehensive income attributable to the parent company was -12,122,679.11, compared to -10,667,174.93 in the previous period, indicating a decline[23] - Basic earnings per share were -0.0191, slightly worse than -0.0174 in the previous period[23] Cash Flow and Liquidity - The net cash flow from operating activities was negative at approximately ¥58.89 million[4] - Cash received from borrowings in Q1 2023 amounted to CNY 309.09 million, primarily from new loans[13] - Cash used for debt repayment in Q1 2023 was CNY 129.73 million, mainly for repaying loans[13] - The company's cash and cash equivalents as of March 31, 2023, were CNY 449.43 million, down from CNY 502.99 million at the end of 2022[17] - Net cash flow from operating activities was -58,893,539.39, an improvement from -78,087,584.40 in the previous period[25] - Cash inflow from financing activities totaled 180,000,000.00, significantly higher than 44,000,000.00 in the previous period[26] - The company reported a net cash outflow from investment activities of -3,361,465.38, contrasting with a net inflow of 74,242,945.10 previously[25] Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥3.11 billion, a decrease of 1.14% from the end of the previous year[9] - The total liabilities as of March 31, 2023, were CNY 1,206.43 million, down from CNY 1,231.39 million at the end of 2022[19] - Total current liabilities as of March 31, 2023, were CNY 1,124.05 million, a decrease from CNY 1,147.32 million at the end of 2022[19] - The equity attributable to shareholders of the listed company was approximately ¥1.85 billion, down 0.60% from the end of the previous year[9] - Total equity attributable to shareholders was CNY 1,849,640,065.09, slightly down from CNY 1,860,804,118.43 year-over-year[33] - The total liabilities and equity amounted to CNY 3,111,471,925.81, compared to CNY 3,147,379,717.98 in the previous year[33] Operational Metrics - The decrease in operating revenue was primarily due to the reduction in the consolidation scope following the decrease in the company's shareholding in Xi'an Aerospace Huawai Chemical Bioengineering Co., Ltd. to 49%[5] - The company reported a significant decrease in other income by 64.70%, mainly due to a reduction in government subsidies received[11] - The company experienced a 122.55% decrease in credit impairment losses, attributed to the reversal of bad debt provisions in the previous period[11] - Total operating costs for Q1 2023 were CNY 159,442,235.14, down from CNY 247,905,638.73 in Q1 2022, reflecting a reduction of 35.6%[33] - R&D expenses decreased to CNY 8,031,700.52 in Q1 2023 from CNY 9,655,709.59 in Q1 2022, a reduction of 16.8%[33] - The company reported interest income of CNY 1.13 million in Q1 2023, an increase from CNY 0.96 million in Q1 2022[22] Shareholder Information - Total number of common shareholders at the end of the reporting period was 72,489[13] - The largest shareholder, Xi'an Aerospace Technology Industry Co., Ltd., holds 183,663,392 shares, accounting for 28.78% of total shares[13]
航天动力(600343) - 2023 Q1 - 季度财报